AU1506399A - Apoptosis inhibitory factor - Google Patents

Apoptosis inhibitory factor

Info

Publication number
AU1506399A
AU1506399A AU15063/99A AU1506399A AU1506399A AU 1506399 A AU1506399 A AU 1506399A AU 15063/99 A AU15063/99 A AU 15063/99A AU 1506399 A AU1506399 A AU 1506399A AU 1506399 A AU1506399 A AU 1506399A
Authority
AU
Australia
Prior art keywords
inhibitory factor
apoptosis inhibitory
apoptosis
factor
inhibitory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15063/99A
Inventor
Yoshiyuki Ohsawa
Yasuo Uchiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of AU1506399A publication Critical patent/AU1506399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU15063/99A 1997-12-12 1998-12-11 Apoptosis inhibitory factor Abandoned AU1506399A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP9-343112 1997-12-12
JP34311297 1997-12-12
JP10-131634 1998-05-14
JP10131634A JPH11225771A (en) 1997-12-12 1998-05-14 Cell death inhibitory factor
PCT/JP1998/005609 WO1999031237A1 (en) 1997-12-12 1998-12-11 Apoptosis inhibitory factor

Publications (1)

Publication Number Publication Date
AU1506399A true AU1506399A (en) 1999-07-05

Family

ID=26466414

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15063/99A Abandoned AU1506399A (en) 1997-12-12 1998-12-11 Apoptosis inhibitory factor

Country Status (3)

Country Link
JP (1) JPH11225771A (en)
AU (1) AU1506399A (en)
WO (1) WO1999031237A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015468A4 (en) 1997-08-29 2000-09-06 Human Genome Sciences Inc Follistatin-3
US6953662B2 (en) 1997-08-29 2005-10-11 Human Genome Sciences, Inc. Follistatin-3

Also Published As

Publication number Publication date
WO1999031237A1 (en) 1999-06-24
JPH11225771A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
AU5711196A (en) Apoptosis inducing molecule i
AU1709299A (en) Mixer-injectors
AU8921698A (en) Follistatin-3
AU9414098A (en) Ascorbyl-phosphoryl-cholesterol
AU6598798A (en) Resorcinyl-triazines
AU2106399A (en) Apoptosis inducing molecule ii
AU1399997A (en) Apoptosis inducers
AU1027499A (en) 32P-polyphosphazene
AU9513298A (en) Fluoranthenopyrans
AU6827898A (en) Detergent-package combination
AU5272198A (en) EMP-charge-eliminator
AU4117497A (en) Micropolarimeter
AU6998698A (en) Dioxacycloalkan-8-one
AU6185898A (en) Clavaspirins
AU8072498A (en) Heregulin-like factor
AU5446499A (en) Apoptosis inducing agents
AU7761998A (en) Korrosionsschutzanstrichstoff
AU8214598A (en) 3-benzylpiperidine
AU1506399A (en) Apoptosis inhibitory factor
AU1479600A (en) Anti-icam-r antibody-induced apoptosis
AU5467099A (en) Novel apoptosis proteins
AU8991998A (en) Renovative pipeliner
AU9183798A (en) Catamaran - bicycle - kayak
AU5391798A (en) Thiamacrolides
AU4469997A (en) Heregulin-gamma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase